Brez internetne povezave — prikazana je shranjena različica strani.

Tevogen Bio Holdi…

USUSD
← Na filter delnic

Tevogen Bio Holdings Inc. (US:TVGN) — Biotechnology: Biological Products (No Diagnostic Substances). Število borz, na katerih se trgujejo delnice družbe: 1. Na tej strani — cena in graf, dividende, največji imetniki in zgodovina števila delnic.

O podjetju

Spletna stran
tevogen.com
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sedež
WARREN, United States
Izvršni direktor
Dr. Ryan H. Saadi M.D., M.P.H.
Zaposleni
18
Delnice v obtoku
6.51 mio. na dan 2026-08-10
Prosto prenosljive delnice
843 310
Tržna kapitalizacija
45.45 mio. USD
Notranje osebe
72.08%
Institucionalni vlagatelji
1.65%
Panoga (SIC)
Biological Products, (No Diagnostic Substances)
Opis

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920, a preclinical trial drug for treating cervical cancer; TVGN 960, a preclinical trial drug for treating oropharyngeal cancer; TVGN 601, a preclinical trial drug for treating multiple sclerosis; TVGN 930, a preclinical trial drug for treating Epstein-Barr virus associated lymphomas; and TVGN 116, a product candidate targeted at hepatitis B. It also offers artificial intelligence platform for drug development. Tevogen Inc. was formerly known as Tevogen Bio Holdings Inc. and changed its name to Tevogen Inc. in July 2026. The company was incorporated in 2020 and is headquartered in Warren, New Jersey.

Borze in oznake

BorzaOznakaValutaCenaVrsta
US USA StocksTVGNUSD7.06 +8.78%navadne delnice

Cena v 3 mesecih

US:TVGN · USD
dan rasti dan padca ex-dividendni datum datum izplačilaPremaknite miško / tapnite dan — otvoritvena, zaključna, najvišja in najnižja cena

Dividende

Ni bilo najdenih izplačil dividend (preverjeno 09.10.2026). Podjetje verjetno ne izplačuje dividend.

Novice ta teden

Novic s spletnega mesta podjetja še ni.

oglas

Največji imetniki

ImetnikDeležDelniceDatum poročila
KHAN SADIQ (Officer)≈17.96%1.17 mio.2025-06-27
DESAI KIRTI (Chief Finan…≈15.25%992 9832026-09-14
PATTON CURTIS L (Directo…≈2.14%139 1922026-09-11
FEIKE JEFFREY L (Directo…≈2.02%131 4352026-09-11
SORDILLO VICTOR J (Direc…≈1.94%126 5392026-09-11
GOH KEOW LIN (Director)≈1.9%123 6782026-09-11
PODLOGAR SUSAN M (Direct…≈1.9%123 6782026-09-11
FLOMENBERG NEAL (Officer…≈1.18%76 9402026-03-13
Vanguard Capital Managem…0.15%23 9762026-06-30
Morgan Stanley0.12%18 8092026-06-30
AQR Capital Management,…0.11%17 2372026-06-30
VANGUARD INDEX FUNDS-Van…0.1%15 1022026-06-30
Goldman Sachs Group Inc0.09%14 1632026-06-30
GOLDMAN SACHS TRUST-Gold…0.09%13 9512026-06-30
Jane Street Group, LLC0.07%11 1752026-06-30
FMR, LLC0.06%9 8262026-06-30
VANGUARD Inst. INDEX Fd.…0.04%7 0352026-06-30
Russell Investments Grou…0.04%6 5322026-06-30
Fidelity Concord Street…0.03%4 0812026-07-31
VANGUARD SCOTTSDALE FUND…0.03%4 0532026-05-31
VANGUARD INDEX FUNDS-Van…0.01%1 8392026-06-30
Tower Research Capital L…0.01%1 4942026-06-30
Fidelity Concord Street…0.01%1 4632026-07-31
UBS Group AG0.01%1 0832026-06-30
Vanguard Fiduciary Trust…0.01%8382026-06-30
Fidelity Concord Street…0%3572026-07-31
VANGUARD SCOTTSDALE FUND…0%3142026-05-31
Fidelity Concord Street…0%3002026-07-31
SAADI RYAN H (Chief Exec…—11.71 mio.2026-09-14